Combination strategy developed by BASF and Givaudan is the first complete replacement for animal testing
The Organisation for Economic Co-operation and Development (OECD) has approved the first overall testing strategy to predict skin allergic reactions without using animals. The strategy was developed in a decade-long collaboration between German chemicals company BASF, and Swiss flavour and fragrance specialist Givaudan. According to Givaudan’s head of in vitro molecular screening, Andreas Natch, it is better at predicting human allergy risks than traditional animal testing.